Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537769 Purified and recombinant antigenic protein associated with abdominal aortic aneurysm (AAA) disease, and diagnostic and therapeutic use thereof
03/25/2003US6537768 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens
03/25/2003US6537766 Correlation with lymphoid cell abnormalities; use in the detection and treatment of lymphomas; cancer
03/25/2003US6537765 GPR10 as a target for identifying weight modulating compounds
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537762 Competitive binding; monoclonal antibodies; immunoassay; use determine if grains or feeds contaminated with mycotoxin producing fungi
03/25/2003US6537756 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP
03/25/2003US6537754 Association of kinesin with sensitivity to chemotherapeutic drugs
03/25/2003US6537753 CaESS1 (gene and encoded isomerase essential to yeast cell growth); isolated, purified nucleic acid; genetic primers, probes and vectors; use diagnosis, detection, prevention, or treatment of C. albicans infections
03/25/2003US6537746 Method for creating polynucleotide and polypeptide sequences
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537558 Methods of producing and using virulence attenuated poxR mutant bacteria
03/25/2003US6537557 Strain 341750 PDK-6
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537554 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
03/25/2003US6537553 Antagonist to E-selectin mediated cell adhesion to endothe-lial cells; reducing inflammation; inhibiting metastasis by carcinogenic cells
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537541 Implantation of HSV-TK retrovirus producer cells to destroy glioma
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003US6537539 Immune cell cytokine
03/25/2003US6537519 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
03/25/2003US6537441 Lower dection limits
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2251262C Nucleic acid encoding a nervous tissue sodium channel
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2173957C Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2098137C Novel protein
03/25/2003CA2083595C Method of inducing plant defense mechanisms
03/25/2003CA2083401C Identification of a novel human receptor tyrosine kinase gene
03/25/2003CA2075182C Retinoid receptor compositions and methods
03/20/2003WO2003023408A1 Compositions and methods for aa4rp assay
03/20/2003WO2003023407A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003WO2003023405A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
03/20/2003WO2003023064A1 Blueberry red ringspot virus, sequences, promoters, and uses thereof
03/20/2003WO2003023041A2 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
03/20/2003WO2003023039A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells
03/20/2003WO2003023038A1 Isolation and use of the desiccation-specific promoter from ds2 gene
03/20/2003WO2003023031A1 Method of evaluating efficacy of nucleic acid therapy
03/20/2003WO2003023027A2 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023013A2 Novel nucleic acids and polypeptides
03/20/2003WO2003023012A2 Crystal structure of interleukin-22 and uses thereof
03/20/2003WO2003023010A2 Sensory neuron receptors
03/20/2003WO2003023009A2 G-protein coupled receptors
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023007A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
03/20/2003WO2003023006A2 Hemocyanin nucleic acids and polypeptides and related vectors, fusion proteins, conjugates, cells and methods of use
03/20/2003WO2003023003A2 Nucleic acid-associated proteins
03/20/2003WO2003023002A2 Novel human proteins, polynucleotides encoding them and methods of using the same
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022998A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022996A2 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022992A2 Mammalian genes; related reagents
03/20/2003WO2003022990A2 Production of fusion proteins and use for identifying binding molecules
03/20/2003WO2003022989A2 Therapeutic agents that inhibit the tup1 pathway
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022885A1 Chemokines
03/20/2003WO2003022884A2 Methods for construction and screening of libraries of chemokine variants
03/20/2003WO2003022883A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022881A2 Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022879A2 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
03/20/2003WO2003022878A2 Subunit respiratory syncytial virus vaccine preparation
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022875A2 Polymorphisms of pd-1
03/20/2003WO2003022874A1 Antagonist peptides to vegr receptor flt-1
03/20/2003WO2003022870A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022868A2 Metal binding proteins and associated methods
03/20/2003WO2003022867A2 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
03/20/2003WO2003022311A1 Adenoviral vector and related system and methods of making and use
03/20/2003WO2003022307A1 Attenuated bacteria useful in vaccines
03/20/2003WO2003022306A2 Bacterial vaccine
03/20/2003WO2003022304A1 Oxynthomodulin for preventing or treating excess weight
03/20/2003WO2003022300A1 Preventives/remedies for bone/joint diseases
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022226A2 Neurotrophic components of the adnf i complex
03/20/2003WO2003022225A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003WO2003022204A2 Measles vaccine vectors and methods of use
03/20/2003WO2003022202A2 Compositions and methods for treatment of cancer
03/20/2003WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/20/2003WO2003022063A1 Method and apparatus for separation of milk, colostrum, and whey
03/20/2003WO2003022039A1 Impartment of virus-resistance with the use of plant protein binding to plant virus transport protein
03/20/2003WO2003008447A8 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination
03/20/2003WO2003004466A3 Dye-sulfenates for dual phototherapy
03/20/2003WO2003002726A3 Cellular reporter gene assay with a ligand amplifying feedback loop
03/20/2003WO2003002597A3 Therapeutic modulation of chemokines using a helminth parasite chemokine-binding protein
03/20/2003WO2003000724A3 Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders
03/20/2003WO2003000280A3 Abin-mediated hepatitis protection